Aequus Pharmaceuticals and Medicom Healthcare have entered into an exclusive agreement to commercialize ophthalmology products in the United States, according to a press release.
The companies will jointly commercialize the U.K.-based Medicom’s range of preservative-free products, prioritizing programs and developing commercialization plans.
Similar to a joint venture, revenues will be shared equally, with investments and contributions made by each party reconciled through a joint profit and loss statement, the release said.
“The science is clear that non-preserved eye medicines are
Uncategorized